Format

Send to

Choose Destination
Expert Rev Clin Pharmacol. 2017 Oct;10(10):1023-1026. doi: 10.1080/17512433.2017.1383894.

Pathways to the elimination of hepatitis C: prioritising access for all.

Author information

1
a Disease Elimination Program , Burnet Institute , Melbourne , Australia.
2
b Department of Epidemiology and Preventive Medicine , Monash University , Melbourne , Australia.
3
c Department of Medicine , The University of Melbourne , Melbourne , Australia.
4
d Department of Infectious Diseases , The Alfred and Monash University , Melbourne , Australia.

KEYWORDS:

Cost-effectiveness; IDU; disease elimination; hepatitis C virus; implementation science; models of care; testing

PMID:
28942660
DOI:
10.1080/17512433.2017.1383894
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center